Status:
COMPLETED
Repeat Nasal Allergen Challenge
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Novartis Pharmaceuticals
Conditions:
Hayfever
Eligibility:
All Genders
18-40 years
Phase:
PHASE2
Brief Summary
This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled a...
Detailed Description
This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled a...
Eligibility Criteria
Inclusion
- Male and female subjects with a history of seasonal (intermittent) atopic rhinitis, aged 18-40 years.
- Otherwise healthy with no health problems that may jeopardize the subjects participating in the study, absence of history of other significant allergies.
Exclusion
- Smokers (use of tobacco products in the previous 3 months).
- Presence of any respiratory disease other than a history of mild stable asthma not requiring treatment and associated with normal lung function (FEV1 \> 80% predicted at screening).
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00290368
Start Date
February 1 2006
End Date
May 1 2006
Last Update
September 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart & Lung Institute Clinical Studies Unit
London, United Kingdom, SW3 6HP